Késia Sindy Alves Ferreira Pereira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Késia Sindy Alves Ferreira Pereira has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Andre Luiz Santos Pessoa
Hospital Infantil Albert Sabin, Fortaleza, Brazil
1 shared publication - Erlane Marques Ribeiro
Division of Neurogenetics and Neuromuscular Disorders Hospital Infantil Albert Sabin Fortaleza Ceará Brazil
1 shared publication - Gustavo Rodrigues Ferreira Gomes
Division of Neurogenetics and Neuromuscular Disorders Hospital Infantil Albert Sabin Fortaleza Ceará Brazil
1 shared publication - Ingred Pimentel Guimarães
From the Departments of Medicine, Ceara State University, Fortaleza, Brazil
1 shared publication - Paulo Ribeiro Nóbrega
Department of Neurology, Universidade Federal do Ceará, Fortaleza, Brazil
1 shared publication - Tamiris Carneiro Mariano
Division of Neurogenetics and Neuromuscular Disorders, Hospital Infantil Albert Sabin, Fortaleza 60410-794, CE, Brazil
1 shared publication
Latest Publications
- Open Access
- 10 August 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (8) , 1184
Bailey-Bloch Congenital Myopathy in Brazilian Patients: A Very Rare Myopathy with Malignant Hyperthermia Susceptibility
Background: Congenital myopathy-13 (CMYP13), also known as Bailey-Bloch congenital myopathy and Native American myopathy (NAM), is a condition caused by biallelic missense pathogenic variants in STAC3, which encodes an important protein necessary for the excitation-relaxation coupling machinery in the muscle. Patients with biallelic pathogenic variants in STAC3 often present with congenital weakness and arthrogryposis, cleft palate, ptosis, myopathic facies, short stature, kyphoscoliosis, and susceptibility to malignant hyperthermia provoked by anesthesia. We present two unrelated cases of Bailey-Bloch congenital myopathy descendants of non-consanguineous parents, which were investigated for delayed psychomotor development and generalized weakness. To the best of our knowledge, these are the first descriptions of CMYP13 in Brazil. In both patients, we found the previously described pathogenic missense variant p.Trp284Ser in homozygosity. Conclusion: We seek to highlight the need for screening for CMYP13 in patients expressing the typical phenotype of the disease even in the absence of Lumbee Native American ancestry, and to raise awareness to possible complications like malignant hyperthermia in Bailey-Bloch congenital myopathy.
- 10 August 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (8) , 1184
Open AccessBailey-Bloch Congenital Myopathy in Brazilian Patients: A Very Rare Myopathy with Malignant Hyperthermia Susceptibility
Background: Congenital myopathy-13 (CMYP13), also known as Bailey-Bloch congenital myopathy and Native American myopathy (NAM), is a condition caused by biallelic missense pathogenic variants in STAC3, which encodes an important protein necessary for the excitation-relaxation coupling machinery in the muscle. Patients with biallelic pathogenic variants in STAC3 often present with congenital weakness and arthrogryposis, cleft palate, ptosis, myopathic facies, short stature, kyphoscoliosis, and susceptibility to malignant hyperthermia provoked by anesthesia. We present two unrelated cases of Bailey-Bloch congenital myopathy descendants of non-consanguineous parents, which were investigated for delayed psychomotor development and generalized weakness. To the best of our knowledge, these are the first descriptions of CMYP13 in Brazil. In both patients, we found the previously described pathogenic missense variant p.Trp284Ser in homozygosity. Conclusion: We seek to highlight the need for screening for CMYP13 in patients expressing the typical phenotype of the disease even in the absence of Lumbee Native American ancestry, and to raise awareness to possible complications like malignant hyperthermia in Bailey-Bloch congenital myopathy.